Banner

Alzheimer’s Disease Treatment Global Market Report 2023 – By Drug Class (Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins), By Drug Type (Cholinesterase Inhibitors, NMDA Receptor Antagonists), By Therapeutics (Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics) – Market Size, Trends, And Market Forecast 2023-2032

Starting Price : $5000.00 | Pages : 250 | Published : January 2023 | SKU CODE : h1179 | Delivery Time: 2-3 business days | Format :


Alzheimer’s diseas treatment refers to a medication designed and developed to treat Alzheimer's. This treatment, which targets the protein beta-amyloid and is an immunotherapy, aids in the reduction of amyloid plaques, which are brain lesions connected to Alzheimer's disease. The progression of this disease causes severe memory impairment and the person may lose the ability to carry out everyday tasks.

The main types of drugs in alzheimer’s disease treatment are cholinesterase inhibitors and NMDA receptor antagonists. Cholinesterase inhibitors (also known as acetylcholinesterase inhibitors) are a class of drugs that prevent acetylcholine from being broken down normally. The different drug classes include cholinergic, memantine, combined drug, AChE inhibitors, and immunoglobulins and involve various therapeutics such as cholinesterase inhibitors, NMDA receptor antagonists, and other therapeutics.

The alzheimer’s disease treatment market research report is one of a series of new reports from The Business Research Company that provides alzheimer’s disease treatment market statistics, including alzheimer’s disease treatment industry global market size, regional shares, competitors with an alzheimer’s disease treatment market share, detailed Alzheimer’s disease treatment market segments, market trends and opportunities, and any further data you may need to thrive in the Alzheimer’s disease treatment industry. This Alzheimer’s disease treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The global alzheimer’s disease treatment market grew from $5.08 billion in 2022 to $5.48 billion in 2023 at a compound annual growth rate (CAGR) of 8.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The alzheimer’s disease treatment market is expected to grow from $7.37 billion in 2027 at a CAGR of 7.7%.

The increasing cases of Alzheimer's are a major factor contributing to the growth of the Alzheimer's treatment market. Alzheimer's is the most common type of dementia. The USA Alzheimer's Association expects that all the states in the US are projected to face a rise of at least 14% in the number of Alzheimer’s patients by 2025 due to the increase in the geriatric population. At the global level, the estimated new cases of Alzheimer’s are expected to grow by 35% to 615,000 by 2030, and by 110% to 959,000 by 2050. Therefore, the increasing prevalence of Alzheimer’s disease is expected to drive the growth of the global Alzheimer’s disease treatment market.

The lack of techniques for diagnosing Alzheimer’s disease (AD) is expected to limit the growth of the global Alzheimer’s disease treatment market. There is no definitive blood test, brain scan, or physical exam to diagnose AD, and so many conditions can produce symptoms like dementia, which is the primary clinical symptom of AD, making the diagnosis complicated. Due to the lack of a single test for diagnosis, specialists such as neurologists, neuropsychologists, geriatricians, and geriatric psychiatrists use a variety of approaches for diagnosis to confirm dementia, but it is still difficult to find the cause, resulting in late diagnosis. Lack of proper and quick diagnosis for AD hampers the market growth as it leads to a reduced number of diagnosed cases and thereby reduces the consumption of AD drugs.

Increasing R&D investments and collaborations as a result of emerging treatment technologies is a key trend in the Alzheimer's disease (AD) treatment market.The Alzheimer's Association is assisting with funds to researchers in search of innovative therapeutic approaches and seeks more government funding for Alzheimer's studies. Technologies such as ß-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitors and anti-amyloid inhibitors are emerging in the AD market. For instance, Comentis and Astellas collaborated and entered the BACE inhibitor field with their peptidomimetic series. Manufacturing firms such as AC Immune, Adamas Pharmaceuticals, INmune Bio, Intra-Cellular Therapies, and vTv Therapeutics are focusing more on R&D investments with their research molecules in clinical trials to achieve a breakthrough in the treatment of Alzheimer's disease.

In January 2020, Biogen Inc., a US-based multinational biotechnology company, acquired Pfizer Inc. for an upfront payment of $75 million with up to $635 million in potential additional development and commercialization milestone payments. Through this acquisition, Biogen plans to develop the Phase 1 asset for the treatment of Sundowning in Alzheimer’s disease (AD) and Irregular Sleep-Wake Rhythm Disorder (ISWRD) in Parkinson’s disease (PD). Pfizer Inc. is an American multinational pharmaceutical corporation engaged in the discovery, development, and manufacture of healthcare products, including medicines and vaccines.

Major players in the alzheimer’s disease treatment market are Allergan, Eisai Co. Ltd., Novartis AG, Pfizer Inc., Merz Pharma, H. Lundbeck A/S Biogen, AstraZeneca, and F. Hoffmann-La Roche Ltd.

North America is the largest region in the alzheimer’s disease treatment market in 2022. Middle East is expected to be the fastest growing region in the global alzheimer’s disease treatment market during the forecast period. The regions covered in the global Alzheimer’s disease treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

The countries covered in the alzheimer’s disease treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The Alzheimer’s disease treatment market includes revenues earned by entities by temporarily improve symptoms of memory loss and problems with thinking and reasoning. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organisations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the chain or as part of other products.

The global Alzheimer's disease treatment market is segmented -

1) By Drug Class: Cholinergic, Memantine, Combined Drug, AChE inhibitors, Immunoglobulins

2) By Drug Type: Cholinesterase Inhibitors, NMDA Receptor Antagonists

3) By Therapeutics: Cholinesterase Inhibitors, NMDA Receptor Antagonists, Other Therapeutics

    Table Of Contents

    1. Executive Summary

    2. Alzheimer’s Disease Treatment Market Characteristics

    3. Alzheimer’s Disease Treatment Market Trends And Strategies

    4. Alzheimer’s Disease Treatment Market – Macro Economic Scenario

    4.1 COVID-19 Impact On Alzheimer’s Disease Treatment Market

    4.2 Ukraine-Russia War Impact On Alzheimer’s Disease Treatment Market

    4.3 Impact Of High Inflation On Alzheimer’s Disease Treatment Market

    5. Alzheimer’s Disease Treatment Market Size And Growth

    5.1. Global Alzheimer’s Disease Treatment Historic Market, 2017-2022, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Alzheimer’s Disease Treatment Forecast Market, 2022-2027F, 2032F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Alzheimer’s Disease Treatment Market Segmentation

    6.1. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Cholinergic

    Memantine

    Combined Drug

    AChE inhibitors

    Immunoglobulins

    6.2. Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Cholinesterase Inhibitors

    NMDA Receptor Antagonists

    6.3. Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    Cholinesterase Inhibitors

    NMDA Receptor Antagonists

    Other Therapeutics

    7. Alzheimer’s Disease Treatment Market Regional And Country Analysis

    7.1. Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    7.2. Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    8. Asia-Pacific Alzheimer’s Disease Treatment Market

    8.1. Asia-Pacific Alzheimer’s Disease Treatment Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    9. China Alzheimer’s Disease Treatment Market

    9.1. China Alzheimer’s Disease Treatment Market Overview

    9.2. China Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F,$ Billion

    10. India Alzheimer’s Disease Treatment Market

    10.1. India Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    11. Japan Alzheimer’s Disease Treatment Market

    11.1. Japan Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    12. Australia Alzheimer’s Disease Treatment Market

    12.1. Australia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    13. Indonesia Alzheimer’s Disease Treatment Market

    13.1. Indonesia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    14. South Korea Alzheimer’s Disease Treatment Market

    14.1. South Korea Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    15. Western Europe Alzheimer’s Disease Treatment Market

    15.1. Western Europe Alzheimer’s Disease Treatment Market Overview

    15.2. Western Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    16. UK Alzheimer’s Disease Treatment Market

    16.1. UK Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    17. Germany Alzheimer’s Disease Treatment Market

    17.1. Germany Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    18. France Alzheimer’s Disease Treatment Market

    18.3. France Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    19. Eastern Europe Alzheimer’s Disease Treatment Market

    19.1. Eastern Europe Alzheimer’s Disease Treatment Market Overview

    19.2. Eastern Europe Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    20. Russia Alzheimer’s Disease Treatment Market

    20.1. Russia Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    21. North America Alzheimer’s Disease Treatment Market

    21.1. North America Alzheimer’s Disease Treatment Market Overview

    21.2. North America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    22. USA Alzheimer’s Disease Treatment Market

    22.1. USA Alzheimer’s Disease Treatment Market Overview

    22.2. USA Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    23. South America Alzheimer’s Disease Treatment Market

    23.1. South America Alzheimer’s Disease Treatment Market Overview

    23.2. South America Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    24. Brazil Alzheimer’s Disease Treatment Market

    24.1. Brazil Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    25. Middle East Alzheimer’s Disease Treatment Market

    25.1. Middle East Alzheimer’s Disease Treatment Market Overview

    25.2. Middle East Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    26. Africa Alzheimer’s Disease Treatment Market

    26.1. Africa Alzheimer’s Disease Treatment Market Overview

    26.2. Africa Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion

    27. Alzheimer’s Disease Treatment Market Competitive Landscape And Company Profiles

    27.1. Alzheimer’s Disease Treatment Market Competitive Landscape

    27.2. Alzheimer’s Disease Treatment Market Company Profiles

    27.2.1. Allergan

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Eisai Co. Ltd.

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Novartis AG

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Pfizer Inc.

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Merz Pharma

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Alzheimer’s Disease Treatment Pipeline Analysis

    29. Key Mergers And Acquisitions In The Alzheimer’s Disease Treatment Market

    30. Alzheimer’s Disease Treatment Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Historic And Forecast Inflation Rates

    31.4. Research Inquiries

    31.5. The Business Research Company

    31.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Table 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Table 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 6: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 7: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 8: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 9: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 10: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 11: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 12: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 13: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 14: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 15: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 16: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 17: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 18: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 19: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 20: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 21: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 22: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 23: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 24: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 25: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 26: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Table 27: Allergan Financial Performance
  • Table 28: Eisai Co. Ltd. Financial Performance
  • Table 29: Novartis AG Financial Performance
  • Table 30: Pfizer Inc. Financial Performance
  • Table 31: Merz Pharma Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2017-2022, $ Billion
  • Figure 2: Global Forecast Market Growth, 2022-2027F, 2032F, $ Billion
  • Figure 3: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 4: Global Alzheimer’s Disease Treatment Market, Segmentation By Drug Type, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 5: Global Alzheimer’s Disease Treatment Market, Segmentation By Therapeutics, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 6: Global Alzheimer’s Disease Treatment Market, Split By Region, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 7: Global Alzheimer’s Disease Treatment Market, Split By Country, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 8: Asia-Pacific, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 9: China, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 10: India, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 11: Japan, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 12: Australia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 13: Indonesia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 14: South Korea, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 15: Western Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 16: UK, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 17: Germany, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 18: France, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 19: Eastern Europe, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 20: Russia, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 21: North America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 22: USA, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 23: South America, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 24: Brazil, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 25: Middle East, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 26: Africa, Alzheimer’s Disease Treatment Market, Segmentation By Drug Class, Historic and Forecast, 2017-2022, 2022-2027F, 2032F, $ Billion
  • Figure 27: Allergan Financial Performance
  • Figure 28: Eisai Co. Ltd. Financial Performance
  • Figure 29: Novartis AG Financial Performance
  • Figure 30: Pfizer Inc. Financial Performance
  • Figure 31: Merz Pharma Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report